Bvf Inc Amarin Corp Plcuk Transaction History

Bvf Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.85 - $3.73 $46.9 Million - $61.4 Million	-16,459,965 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.24 - $5.18 $16.4 Million - $26.2 Million	5,052,783 Added 44.29%	16,459,965 $55.5 Million
Q3 2021 Nov 15, 2021	BUY	$3.94 - $5.84 $38.2 Million - $56.6 Million	9,691,201 Added 564.76%	11,407,182 $58.2 Million
Q1 2021 May 17, 2021	SELL	$5.03 - $8.8 $45.5 Million - $79.6 Million	-9,045,612 Reduced 84.05%	1,715,981 $10.7 Million
Q4 2020 Feb 12, 2021	BUY	$4.04 - $5.31 $39 Million - $51.3 Million	9,661,593 Added 878.33%	10,761,593 $52.6 Million
Q3 2020 Nov 13, 2020	BUY	$3.64 - $7.76 $4 Million - $8.54 Million	1,100,000 New	1,100,000 $4.63 Million

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $185M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.